The big story in oncology of late has been the rise of immunotherapy. As promising as these treatments are, some patients don’t respond as well as others.

Caltech researchers have shown in mouse models that gut bacteria can encourage the progression of some Parkinson’s disease hallmarks.

Researchers led by Yale University have singled out a protein that is responsible for transporting LDL cholesterol into cells. This target could lead to new…

Several observational studies suggest that patients with diabetes who take metformin may have a lower cancer risk than people who are not on the drug. But why?

An international team has created antibody fragments, dubbed nanobodies, to address challenges posed by an ion channel important in inflammation.

One of the most active research endeavors in immuno-oncology involves engineering human viruses into weapons that can fight cancer. Now a group of scientists…

A Benaroya Research Institute-led team has discovered that T cell fatigue may potentially boost therapies for diabetes and other autoimmune diseases.

The gene-editing approach called CRISPR-Cas9 has been grabbing headlines for its potential to address diseases ranging from cancer to sickle cell disease—but…

Research